Summer Infant, Inc. (NASDAQ:SUMR) has received a consensus broker rating score of 1.00 (Strong Buy) from the one brokers that provide coverage for the stock, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy rating.
Analysts have set a 1 year consensus target price of $1.50 for the company and are predicting that the company will post ($0.01) EPS for the current quarter, according to Zacks. Zacks has also assigned Summer Infant an industry rank of 202 out of 257 based on the ratings given to its competitors.
A number of equities research analysts have issued reports on the company. ValuEngine raised Summer Infant from a “sell” rating to a “hold” rating in a research report on Saturday, August 18th. Zacks Investment Research raised Summer Infant from a “hold” rating to a “buy” rating and set a $1.50 price target for the company in a research report on Wednesday, October 10th.
Shares of NASDAQ:SUMR opened at $1.06 on Thursday. Summer Infant has a 52 week low of $0.72 and a 52 week high of $1.98. The company has a quick ratio of 1.17, a current ratio of 1.98 and a debt-to-equity ratio of 3.83.
Summer Infant (NASDAQ:SUMR) last posted its quarterly earnings results on Thursday, November 1st. The company reported ($0.01) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.05 by ($0.06). Summer Infant had a negative net margin of 2.22% and a negative return on equity of 0.69%. The firm had revenue of $43.84 million for the quarter, compared to analysts’ expectations of $47.71 million.
Summer Infant Company Profile
Summer Infant, Inc, together with its subsidiaries, designs, markets, and distributes branded juvenile health, safety, and wellness products primarily in North America. The company markets approximately 1,100 products in various product categories, such as monitoring, safety, nursery, baby gear, and feeding products under the Summer Infant, SwaddleMe, and Born Free brand names.
Read More: Moving Average (MA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Summer Infant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Summer Infant and related companies with MarketBeat.com's FREE daily email newsletter.